Top20
Insights+
Viewpoints
Biopharma
MedTech
DigiHealth
AnimalHealth
R&D
M&A
Events
Bespoke

Tags : JZP-258

Jazz Reports Results of JZP-258 in a P-III Study to Treat Cataplexy and Excessive Daytime Sleepiness in Patients with Narcolepsy

Jazz Reports Results of JZP-258 in a P-III Study to

Tuba Khan September 26, 2019

Shots: &readmore

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Weekly Snapshot

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

November 19, 2021

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Regulatory

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

November 19, 2021

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Regulatory

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

November 19, 2021

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Clinical Trials

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

November 19, 2021

Categories

Animal Health
Biosimilars
Biotech
Clinical Trials
COVID-19
DigiHealth
Events
Exclusive Interview
Insights+
M&A
MedTech
Pharma
Regulatory
Top 20
Viewpoints
Weekly Snapshot

Related Topics

AbbVie Acceptance Acquire Agreement Amgen approval AstraZeneca Bayer Biosimilar BMS Boehringer Ingelheim Collaborates Collaboration Commercialize COVID-19 Develop Development Eli Lilly Exclusive FDA Gilead GSK Janssen Launches License License Agreement Lilly Merck Novartis P-III patients Pfizer receives Regeneron Report reports results Roche Sanofi Signs study Takeda Treat Treatment US

Company

About us
Privacy Policy
Terms & Conditions
Cookies Policy
Newsletter
PharmaShots App
App Privacy Policy
Contact Us

Copyright © 2020 Digiqole. All Right Reserved.